nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CALM3—ulcerative colitis	0.516	0.9	CbGaD
Loperamide—ABCB1—ulcerative colitis	0.0576	0.1	CbGaD
Loperamide—CYP2B6—Nicotine—ulcerative colitis	0.0269	0.0963	CbGbCtD
Loperamide—CYP2B6—Cholecalciferol—ulcerative colitis	0.0241	0.0864	CbGbCtD
Loperamide—CYP2C8—Nicotine—ulcerative colitis	0.0203	0.0729	CbGbCtD
Loperamide—CYP3A4—Budesonide—ulcerative colitis	0.019	0.0679	CbGbCtD
Loperamide—CYP2C8—Cholecalciferol—ulcerative colitis	0.0182	0.0654	CbGbCtD
Loperamide—ABCB1—Methylprednisolone—ulcerative colitis	0.0141	0.0507	CbGbCtD
Loperamide—CYP2D6—Nicotine—ulcerative colitis	0.013	0.0465	CbGbCtD
Loperamide—CYP2C8—Hydrocortisone—ulcerative colitis	0.0127	0.0455	CbGbCtD
Loperamide—CYP2D6—Cholecalciferol—ulcerative colitis	0.0116	0.0417	CbGbCtD
Loperamide—CYP2B6—Dexamethasone—ulcerative colitis	0.0104	0.0374	CbGbCtD
Loperamide—ABCB1—Betamethasone—ulcerative colitis	0.00919	0.0329	CbGbCtD
Loperamide—ABCB1—Prednisolone—ulcerative colitis	0.00907	0.0325	CbGbCtD
Loperamide—ABCB1—Hydrocortisone—ulcerative colitis	0.00859	0.0308	CbGbCtD
Loperamide—ABCB1—Prednisone—ulcerative colitis	0.00856	0.0307	CbGbCtD
Loperamide—CYP3A4—Methylprednisolone—ulcerative colitis	0.00847	0.0303	CbGbCtD
Loperamide—CYP3A4—Nicotine—ulcerative colitis	0.00825	0.0296	CbGbCtD
Loperamide—CYP2C8—Dexamethasone—ulcerative colitis	0.0079	0.0283	CbGbCtD
Loperamide—CYP3A4—Cholecalciferol—ulcerative colitis	0.0074	0.0265	CbGbCtD
Loperamide—CYP3A4—Triamcinolone—ulcerative colitis	0.00642	0.023	CbGbCtD
Loperamide—CYP3A4—Betamethasone—ulcerative colitis	0.0055	0.0197	CbGbCtD
Loperamide—CYP3A4—Prednisolone—ulcerative colitis	0.00543	0.0195	CbGbCtD
Loperamide—ABCB1—Dexamethasone—ulcerative colitis	0.00534	0.0192	CbGbCtD
Loperamide—CYP3A4—Hydrocortisone—ulcerative colitis	0.00515	0.0185	CbGbCtD
Loperamide—CYP3A4—Prednisone—ulcerative colitis	0.00513	0.0184	CbGbCtD
Loperamide—CYP2D6—Dexamethasone—ulcerative colitis	0.00504	0.0181	CbGbCtD
Loperamide—CYP3A4—Dexamethasone—ulcerative colitis	0.0032	0.0115	CbGbCtD
Loperamide—POMC—lymphoid tissue—ulcerative colitis	0.000344	0.125	CbGeAlD
Loperamide—POMC—digestive system—ulcerative colitis	0.00034	0.124	CbGeAlD
Loperamide—Gastrointestinal disorder—Nicotine—ulcerative colitis	0.000293	0.0057	CcSEcCtD
Loperamide—Fatigue—Nicotine—ulcerative colitis	0.000292	0.00569	CcSEcCtD
Loperamide—Anaphylactoid reaction—Prednisolone—ulcerative colitis	0.000291	0.00566	CcSEcCtD
Loperamide—Constipation—Nicotine—ulcerative colitis	0.00029	0.00565	CcSEcCtD
Loperamide—Anaphylactoid reaction—Hydrocortisone—ulcerative colitis	0.000284	0.00553	CcSEcCtD
Loperamide—Flatulence—Budesonide—ulcerative colitis	0.000282	0.00549	CcSEcCtD
Loperamide—Erythema multiforme—Azathioprine—ulcerative colitis	0.000278	0.0054	CcSEcCtD
Loperamide—Gastrointestinal pain—Nicotine—ulcerative colitis	0.000277	0.0054	CcSEcCtD
Loperamide—Dermatitis bullous—Triamcinolone—ulcerative colitis	0.000271	0.00527	CcSEcCtD
Loperamide—Urticaria—Nicotine—ulcerative colitis	0.00027	0.00525	CcSEcCtD
Loperamide—Abdominal pain—Nicotine—ulcerative colitis	0.000268	0.00522	CcSEcCtD
Loperamide—Anaphylactoid reaction—Triamcinolone—ulcerative colitis	0.000267	0.00521	CcSEcCtD
Loperamide—Anaphylactoid reaction—Methylprednisolone—ulcerative colitis	0.000267	0.00519	CcSEcCtD
Loperamide—Immune system disorder—Azathioprine—ulcerative colitis	0.000265	0.00516	CcSEcCtD
Loperamide—Urinary tract disorder—Mesalazine—ulcerative colitis	0.000264	0.00514	CcSEcCtD
Loperamide—Urethral disorder—Mesalazine—ulcerative colitis	0.000262	0.0051	CcSEcCtD
Loperamide—Angioedema—Budesonide—ulcerative colitis	0.000262	0.00509	CcSEcCtD
Loperamide—Hypersensitivity—Mercaptopurine—ulcerative colitis	0.000258	0.00502	CcSEcCtD
Loperamide—POMC—liver—ulcerative colitis	0.000253	0.0923	CbGeAlD
Loperamide—Erythema multiforme—Mesalazine—ulcerative colitis	0.000253	0.00492	CcSEcCtD
Loperamide—Loss of consciousness—Budesonide—ulcerative colitis	0.000252	0.0049	CcSEcCtD
Loperamide—Abdominal pain upper—Hydrocortisone—ulcerative colitis	0.000251	0.00489	CcSEcCtD
Loperamide—Hypersensitivity—Nicotine—ulcerative colitis	0.00025	0.00487	CcSEcCtD
Loperamide—Dermatitis bullous—Dexamethasone—ulcerative colitis	0.000246	0.00478	CcSEcCtD
Loperamide—Dermatitis bullous—Betamethasone—ulcerative colitis	0.000246	0.00478	CcSEcCtD
Loperamide—Abdominal distension—Prednisolone—ulcerative colitis	0.000245	0.00477	CcSEcCtD
Loperamide—Asthenia—Nicotine—ulcerative colitis	0.000243	0.00474	CcSEcCtD
Loperamide—Anaphylactoid reaction—Betamethasone—ulcerative colitis	0.000243	0.00472	CcSEcCtD
Loperamide—Anaphylactoid reaction—Dexamethasone—ulcerative colitis	0.000243	0.00472	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Budesonide—ulcerative colitis	0.000242	0.00471	CcSEcCtD
Loperamide—Immune system disorder—Mesalazine—ulcerative colitis	0.000242	0.0047	CcSEcCtD
Loperamide—Discomfort—Budesonide—ulcerative colitis	0.000241	0.00469	CcSEcCtD
Loperamide—Pruritus—Nicotine—ulcerative colitis	0.00024	0.00467	CcSEcCtD
Loperamide—Diarrhoea—Mercaptopurine—ulcerative colitis	0.00024	0.00466	CcSEcCtD
Loperamide—Abdominal distension—Hydrocortisone—ulcerative colitis	0.000239	0.00466	CcSEcCtD
Loperamide—Dry mouth—Budesonide—ulcerative colitis	0.000238	0.00464	CcSEcCtD
Loperamide—Anaphylactic shock—Budesonide—ulcerative colitis	0.000234	0.00455	CcSEcCtD
Loperamide—Diarrhoea—Nicotine—ulcerative colitis	0.000232	0.00452	CcSEcCtD
Loperamide—Flatulence—Mesalazine—ulcerative colitis	0.000229	0.00447	CcSEcCtD
Loperamide—Nervous system disorder—Budesonide—ulcerative colitis	0.000229	0.00446	CcSEcCtD
Loperamide—Skin disorder—Budesonide—ulcerative colitis	0.000227	0.00442	CcSEcCtD
Loperamide—Abdominal distension—Triamcinolone—ulcerative colitis	0.000225	0.00438	CcSEcCtD
Loperamide—Abdominal distension—Methylprednisolone—ulcerative colitis	0.000225	0.00437	CcSEcCtD
Loperamide—Dizziness—Nicotine—ulcerative colitis	0.000224	0.00437	CcSEcCtD
Loperamide—Vomiting—Mercaptopurine—ulcerative colitis	0.000223	0.00433	CcSEcCtD
Loperamide—Rash—Mercaptopurine—ulcerative colitis	0.000221	0.0043	CcSEcCtD
Loperamide—Dermatitis—Mercaptopurine—ulcerative colitis	0.000221	0.00429	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000216	0.00421	CcSEcCtD
Loperamide—Vomiting—Nicotine—ulcerative colitis	0.000216	0.0042	CcSEcCtD
Loperamide—Discomfort—Azathioprine—ulcerative colitis	0.000215	0.00419	CcSEcCtD
Loperamide—Rash—Nicotine—ulcerative colitis	0.000214	0.00416	CcSEcCtD
Loperamide—Dermatitis—Nicotine—ulcerative colitis	0.000214	0.00416	CcSEcCtD
Loperamide—Angioedema—Mesalazine—ulcerative colitis	0.000213	0.00414	CcSEcCtD
Loperamide—Headache—Nicotine—ulcerative colitis	0.000213	0.00414	CcSEcCtD
Loperamide—Nausea—Mercaptopurine—ulcerative colitis	0.000208	0.00405	CcSEcCtD
Loperamide—Somnolence—Budesonide—ulcerative colitis	0.000208	0.00404	CcSEcCtD
Loperamide—Dyspepsia—Budesonide—ulcerative colitis	0.000206	0.004	CcSEcCtD
Loperamide—Loss of consciousness—Mesalazine—ulcerative colitis	0.000205	0.00398	CcSEcCtD
Loperamide—Skin disorder—Azathioprine—ulcerative colitis	0.000203	0.00394	CcSEcCtD
Loperamide—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000202	0.00393	CcSEcCtD
Loperamide—Nausea—Nicotine—ulcerative colitis	0.000202	0.00392	CcSEcCtD
Loperamide—Fatigue—Budesonide—ulcerative colitis	0.000201	0.00392	CcSEcCtD
Loperamide—Constipation—Budesonide—ulcerative colitis	0.0002	0.00389	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.000197	0.00383	CcSEcCtD
Loperamide—Discomfort—Mesalazine—ulcerative colitis	0.000196	0.00381	CcSEcCtD
Loperamide—Dry mouth—Mesalazine—ulcerative colitis	0.000194	0.00377	CcSEcCtD
Loperamide—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000191	0.00372	CcSEcCtD
Loperamide—Anaphylactic shock—Mesalazine—ulcerative colitis	0.00019	0.0037	CcSEcCtD
Loperamide—Nervous system disorder—Mesalazine—ulcerative colitis	0.000186	0.00363	CcSEcCtD
Loperamide—Urticaria—Budesonide—ulcerative colitis	0.000186	0.00361	CcSEcCtD
Loperamide—Abdominal pain—Budesonide—ulcerative colitis	0.000185	0.0036	CcSEcCtD
Loperamide—Skin disorder—Mesalazine—ulcerative colitis	0.000185	0.00359	CcSEcCtD
Loperamide—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.00018	0.00351	CcSEcCtD
Loperamide—Abdominal distension—Prednisone—ulcerative colitis	0.000178	0.00346	CcSEcCtD
Loperamide—Hypersensitivity—Budesonide—ulcerative colitis	0.000172	0.00335	CcSEcCtD
Loperamide—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000172	0.00334	CcSEcCtD
Loperamide—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000171	0.00332	CcSEcCtD
Loperamide—Somnolence—Mesalazine—ulcerative colitis	0.000169	0.00329	CcSEcCtD
Loperamide—Asthenia—Budesonide—ulcerative colitis	0.000168	0.00326	CcSEcCtD
Loperamide—Dyspepsia—Mesalazine—ulcerative colitis	0.000167	0.00326	CcSEcCtD
Loperamide—Pruritus—Budesonide—ulcerative colitis	0.000165	0.00322	CcSEcCtD
Loperamide—Abdominal pain—Azathioprine—ulcerative colitis	0.000165	0.00321	CcSEcCtD
Loperamide—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000164	0.00319	CcSEcCtD
Loperamide—Fatigue—Mesalazine—ulcerative colitis	0.000164	0.00319	CcSEcCtD
Loperamide—Constipation—Mesalazine—ulcerative colitis	0.000162	0.00316	CcSEcCtD
Loperamide—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000161	0.00314	CcSEcCtD
Loperamide—Diarrhoea—Budesonide—ulcerative colitis	0.00016	0.00311	CcSEcCtD
Loperamide—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000155	0.00302	CcSEcCtD
Loperamide—Angioedema—Prednisolone—ulcerative colitis	0.000155	0.00302	CcSEcCtD
Loperamide—Dizziness—Budesonide—ulcerative colitis	0.000155	0.00301	CcSEcCtD
Loperamide—Hypersensitivity—Azathioprine—ulcerative colitis	0.000154	0.00299	CcSEcCtD
Loperamide—Angioedema—Hydrocortisone—ulcerative colitis	0.000151	0.00294	CcSEcCtD
Loperamide—Urticaria—Mesalazine—ulcerative colitis	0.000151	0.00294	CcSEcCtD
Loperamide—Abdominal pain—Mesalazine—ulcerative colitis	0.00015	0.00292	CcSEcCtD
Loperamide—CALM3—smooth muscle tissue—ulcerative colitis	0.00015	0.0546	CbGeAlD
Loperamide—Loss of consciousness—Prednisolone—ulcerative colitis	0.000149	0.0029	CcSEcCtD
Loperamide—Vomiting—Budesonide—ulcerative colitis	0.000149	0.00289	CcSEcCtD
Loperamide—Rash—Budesonide—ulcerative colitis	0.000147	0.00287	CcSEcCtD
Loperamide—Dermatitis—Budesonide—ulcerative colitis	0.000147	0.00286	CcSEcCtD
Loperamide—Headache—Budesonide—ulcerative colitis	0.000146	0.00285	CcSEcCtD
Loperamide—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000146	0.00283	CcSEcCtD
Loperamide—Diarrhoea—Azathioprine—ulcerative colitis	0.000143	0.00278	CcSEcCtD
Loperamide—Discomfort—Prednisolone—ulcerative colitis	0.000143	0.00278	CcSEcCtD
Loperamide—Angioedema—Triamcinolone—ulcerative colitis	0.000142	0.00277	CcSEcCtD
Loperamide—Angioedema—Methylprednisolone—ulcerative colitis	0.000142	0.00277	CcSEcCtD
Loperamide—Hypersensitivity—Mesalazine—ulcerative colitis	0.00014	0.00273	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.00014	0.00272	CcSEcCtD
Loperamide—Discomfort—Hydrocortisone—ulcerative colitis	0.000139	0.00271	CcSEcCtD
Loperamide—Nausea—Budesonide—ulcerative colitis	0.000139	0.0027	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000138	0.00269	CcSEcCtD
Loperamide—Dizziness—Azathioprine—ulcerative colitis	0.000138	0.00269	CcSEcCtD
Loperamide—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000137	0.00267	CcSEcCtD
Loperamide—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000137	0.00266	CcSEcCtD
Loperamide—Asthenia—Mesalazine—ulcerative colitis	0.000136	0.00265	CcSEcCtD
Loperamide—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000135	0.00263	CcSEcCtD
Loperamide—Pruritus—Mesalazine—ulcerative colitis	0.000134	0.00262	CcSEcCtD
Loperamide—Vomiting—Azathioprine—ulcerative colitis	0.000133	0.00258	CcSEcCtD
Loperamide—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000133	0.00258	CcSEcCtD
Loperamide—Rash—Azathioprine—ulcerative colitis	0.000132	0.00256	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000132	0.00256	CcSEcCtD
Loperamide—Dermatitis—Azathioprine—ulcerative colitis	0.000131	0.00256	CcSEcCtD
Loperamide—Skin disorder—Hydrocortisone—ulcerative colitis	0.000131	0.00255	CcSEcCtD
Loperamide—Discomfort—Triamcinolone—ulcerative colitis	0.000131	0.00255	CcSEcCtD
Loperamide—Discomfort—Methylprednisolone—ulcerative colitis	0.000131	0.00255	CcSEcCtD
Loperamide—Headache—Azathioprine—ulcerative colitis	0.000131	0.00254	CcSEcCtD
Loperamide—Diarrhoea—Mesalazine—ulcerative colitis	0.00013	0.00253	CcSEcCtD
Loperamide—Dry mouth—Triamcinolone—ulcerative colitis	0.00013	0.00253	CcSEcCtD
Loperamide—Angioedema—Betamethasone—ulcerative colitis	0.000129	0.00252	CcSEcCtD
Loperamide—Angioedema—Dexamethasone—ulcerative colitis	0.000129	0.00252	CcSEcCtD
Loperamide—Immune system disorder—Prednisone—ulcerative colitis	0.000128	0.00249	CcSEcCtD
Loperamide—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000127	0.00248	CcSEcCtD
Loperamide—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000127	0.00247	CcSEcCtD
Loperamide—Dizziness—Mesalazine—ulcerative colitis	0.000126	0.00245	CcSEcCtD
Loperamide—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000124	0.00242	CcSEcCtD
Loperamide—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000124	0.00242	CcSEcCtD
Loperamide—Loss of consciousness—Betamethasone—ulcerative colitis	0.000124	0.00242	CcSEcCtD
Loperamide—Nausea—Azathioprine—ulcerative colitis	0.000124	0.00241	CcSEcCtD
Loperamide—Skin disorder—Methylprednisolone—ulcerative colitis	0.000123	0.0024	CcSEcCtD
Loperamide—CALM2—epithelium—ulcerative colitis	0.000122	0.0445	CbGeAlD
Loperamide—CALM1—epithelium—ulcerative colitis	0.000122	0.0443	CbGeAlD
Loperamide—Vomiting—Mesalazine—ulcerative colitis	0.000121	0.00235	CcSEcCtD
Loperamide—Rash—Mesalazine—ulcerative colitis	0.00012	0.00233	CcSEcCtD
Loperamide—Dermatitis—Mesalazine—ulcerative colitis	0.00012	0.00233	CcSEcCtD
Loperamide—Headache—Mesalazine—ulcerative colitis	0.000119	0.00232	CcSEcCtD
Loperamide—Discomfort—Dexamethasone—ulcerative colitis	0.000119	0.00232	CcSEcCtD
Loperamide—Discomfort—Betamethasone—ulcerative colitis	0.000119	0.00232	CcSEcCtD
Loperamide—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000119	0.00232	CcSEcCtD
Loperamide—CALM2—smooth muscle tissue—ulcerative colitis	0.000118	0.0429	CbGeAlD
Loperamide—CALM1—smooth muscle tissue—ulcerative colitis	0.000117	0.0427	CbGeAlD
Loperamide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000117	0.00227	CcSEcCtD
Loperamide—Fatigue—Hydrocortisone—ulcerative colitis	0.000116	0.00227	CcSEcCtD
Loperamide—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000115	0.00225	CcSEcCtD
Loperamide—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000115	0.00225	CcSEcCtD
Loperamide—Nervous system disorder—Betamethasone—ulcerative colitis	0.000113	0.0022	CcSEcCtD
Loperamide—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000113	0.0022	CcSEcCtD
Loperamide—Nausea—Mesalazine—ulcerative colitis	0.000113	0.0022	CcSEcCtD
Loperamide—Angioedema—Prednisone—ulcerative colitis	0.000113	0.00219	CcSEcCtD
Loperamide—Dyspepsia—Triamcinolone—ulcerative colitis	0.000112	0.00218	CcSEcCtD
Loperamide—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000112	0.00218	CcSEcCtD
Loperamide—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.00011	0.00215	CcSEcCtD
Loperamide—Urticaria—Prednisolone—ulcerative colitis	0.00011	0.00214	CcSEcCtD
Loperamide—Fatigue—Triamcinolone—ulcerative colitis	0.00011	0.00214	CcSEcCtD
Loperamide—Fatigue—Methylprednisolone—ulcerative colitis	0.000109	0.00213	CcSEcCtD
Loperamide—Loss of consciousness—Prednisone—ulcerative colitis	0.000108	0.00211	CcSEcCtD
Loperamide—Urticaria—Hydrocortisone—ulcerative colitis	0.000107	0.00209	CcSEcCtD
Loperamide—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000107	0.00208	CcSEcCtD
Loperamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000104	0.00203	CcSEcCtD
Loperamide—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000104	0.00202	CcSEcCtD
Loperamide—Discomfort—Prednisone—ulcerative colitis	0.000104	0.00202	CcSEcCtD
Loperamide—Hypersensitivity—Prednisolone—ulcerative colitis	0.000102	0.00198	CcSEcCtD
Loperamide—Dyspepsia—Dexamethasone—ulcerative colitis	0.000102	0.00198	CcSEcCtD
Loperamide—Dyspepsia—Betamethasone—ulcerative colitis	0.000102	0.00198	CcSEcCtD
Loperamide—Urticaria—Triamcinolone—ulcerative colitis	0.000101	0.00197	CcSEcCtD
Loperamide—Urticaria—Methylprednisolone—ulcerative colitis	0.000101	0.00196	CcSEcCtD
Loperamide—Anaphylactic shock—Prednisone—ulcerative colitis	0.000101	0.00196	CcSEcCtD
Loperamide—Abdominal pain—Methylprednisolone—ulcerative colitis	0.0001	0.00195	CcSEcCtD
Loperamide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	9.97e-05	0.00194	CcSEcCtD
Loperamide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	9.97e-05	0.00194	CcSEcCtD
Loperamide—Hypersensitivity—Hydrocortisone—ulcerative colitis	9.96e-05	0.00194	CcSEcCtD
Loperamide—Fatigue—Dexamethasone—ulcerative colitis	9.95e-05	0.00194	CcSEcCtD
Loperamide—Fatigue—Betamethasone—ulcerative colitis	9.95e-05	0.00194	CcSEcCtD
Loperamide—Nervous system disorder—Prednisone—ulcerative colitis	9.86e-05	0.00192	CcSEcCtD
Loperamide—Skin disorder—Prednisone—ulcerative colitis	9.77e-05	0.0019	CcSEcCtD
Loperamide—Asthenia—Hydrocortisone—ulcerative colitis	9.69e-05	0.00189	CcSEcCtD
Loperamide—Pruritus—Hydrocortisone—ulcerative colitis	9.56e-05	0.00186	CcSEcCtD
Loperamide—Gastrointestinal pain—Betamethasone—ulcerative colitis	9.44e-05	0.00184	CcSEcCtD
Loperamide—Gastrointestinal pain—Dexamethasone—ulcerative colitis	9.44e-05	0.00184	CcSEcCtD
Loperamide—CALM2—lymphoid tissue—ulcerative colitis	9.4e-05	0.0343	CbGeAlD
Loperamide—Hypersensitivity—Triamcinolone—ulcerative colitis	9.37e-05	0.00182	CcSEcCtD
Loperamide—CALM1—lymphoid tissue—ulcerative colitis	9.36e-05	0.0341	CbGeAlD
Loperamide—Hypersensitivity—Methylprednisolone—ulcerative colitis	9.35e-05	0.00182	CcSEcCtD
Loperamide—CALM2—digestive system—ulcerative colitis	9.29e-05	0.0338	CbGeAlD
Loperamide—CALM1—digestive system—ulcerative colitis	9.25e-05	0.0337	CbGeAlD
Loperamide—Diarrhoea—Hydrocortisone—ulcerative colitis	9.25e-05	0.0018	CcSEcCtD
Loperamide—Urticaria—Dexamethasone—ulcerative colitis	9.17e-05	0.00179	CcSEcCtD
Loperamide—Urticaria—Betamethasone—ulcerative colitis	9.17e-05	0.00179	CcSEcCtD
Loperamide—Dizziness—Prednisolone—ulcerative colitis	9.15e-05	0.00178	CcSEcCtD
Loperamide—Asthenia—Triamcinolone—ulcerative colitis	9.13e-05	0.00178	CcSEcCtD
Loperamide—Abdominal pain—Betamethasone—ulcerative colitis	9.13e-05	0.00178	CcSEcCtD
Loperamide—Abdominal pain—Dexamethasone—ulcerative colitis	9.13e-05	0.00178	CcSEcCtD
Loperamide—Asthenia—Methylprednisolone—ulcerative colitis	9.11e-05	0.00177	CcSEcCtD
Loperamide—Pruritus—Triamcinolone—ulcerative colitis	9e-05	0.00175	CcSEcCtD
Loperamide—Pruritus—Methylprednisolone—ulcerative colitis	8.98e-05	0.00175	CcSEcCtD
Loperamide—Dizziness—Hydrocortisone—ulcerative colitis	8.94e-05	0.00174	CcSEcCtD
Loperamide—Dyspepsia—Prednisone—ulcerative colitis	8.85e-05	0.00172	CcSEcCtD
Loperamide—CALM3—liver—ulcerative colitis	8.81e-05	0.0321	CbGeAlD
Loperamide—Rash—Prednisolone—ulcerative colitis	8.72e-05	0.0017	CcSEcCtD
Loperamide—Dermatitis—Prednisolone—ulcerative colitis	8.72e-05	0.0017	CcSEcCtD
Loperamide—Diarrhoea—Methylprednisolone—ulcerative colitis	8.69e-05	0.00169	CcSEcCtD
Loperamide—Fatigue—Prednisone—ulcerative colitis	8.67e-05	0.00169	CcSEcCtD
Loperamide—Headache—Prednisolone—ulcerative colitis	8.67e-05	0.00169	CcSEcCtD
Loperamide—Constipation—Prednisone—ulcerative colitis	8.6e-05	0.00167	CcSEcCtD
Loperamide—Vomiting—Hydrocortisone—ulcerative colitis	8.59e-05	0.00167	CcSEcCtD
Loperamide—Toremifene—ABCB1—ulcerative colitis	8.55e-05	0.221	CrCbGaD
Loperamide—Rash—Hydrocortisone—ulcerative colitis	8.52e-05	0.00166	CcSEcCtD
Loperamide—Dermatitis—Hydrocortisone—ulcerative colitis	8.51e-05	0.00166	CcSEcCtD
Loperamide—Headache—Hydrocortisone—ulcerative colitis	8.46e-05	0.00165	CcSEcCtD
Loperamide—Dizziness—Triamcinolone—ulcerative colitis	8.41e-05	0.00164	CcSEcCtD
Loperamide—Dizziness—Methylprednisolone—ulcerative colitis	8.39e-05	0.00163	CcSEcCtD
Loperamide—Asthenia—Dexamethasone—ulcerative colitis	8.28e-05	0.00161	CcSEcCtD
Loperamide—Asthenia—Betamethasone—ulcerative colitis	8.28e-05	0.00161	CcSEcCtD
Loperamide—Gastrointestinal pain—Prednisone—ulcerative colitis	8.22e-05	0.0016	CcSEcCtD
Loperamide—Nausea—Prednisolone—ulcerative colitis	8.22e-05	0.0016	CcSEcCtD
Loperamide—Pruritus—Betamethasone—ulcerative colitis	8.17e-05	0.00159	CcSEcCtD
Loperamide—Pruritus—Dexamethasone—ulcerative colitis	8.17e-05	0.00159	CcSEcCtD
Loperamide—Vomiting—Triamcinolone—ulcerative colitis	8.09e-05	0.00157	CcSEcCtD
Loperamide—Vomiting—Methylprednisolone—ulcerative colitis	8.07e-05	0.00157	CcSEcCtD
Loperamide—Nausea—Hydrocortisone—ulcerative colitis	8.03e-05	0.00156	CcSEcCtD
Loperamide—Rash—Triamcinolone—ulcerative colitis	8.02e-05	0.00156	CcSEcCtD
Loperamide—Dermatitis—Triamcinolone—ulcerative colitis	8.01e-05	0.00156	CcSEcCtD
Loperamide—Rash—Methylprednisolone—ulcerative colitis	8e-05	0.00156	CcSEcCtD
Loperamide—Dermatitis—Methylprednisolone—ulcerative colitis	8e-05	0.00156	CcSEcCtD
Loperamide—Urticaria—Prednisone—ulcerative colitis	7.99e-05	0.00155	CcSEcCtD
Loperamide—Headache—Triamcinolone—ulcerative colitis	7.97e-05	0.00155	CcSEcCtD
Loperamide—Headache—Methylprednisolone—ulcerative colitis	7.95e-05	0.00155	CcSEcCtD
Loperamide—Abdominal pain—Prednisone—ulcerative colitis	7.95e-05	0.00155	CcSEcCtD
Loperamide—Diarrhoea—Dexamethasone—ulcerative colitis	7.9e-05	0.00154	CcSEcCtD
Loperamide—Diarrhoea—Betamethasone—ulcerative colitis	7.9e-05	0.00154	CcSEcCtD
Loperamide—Dizziness—Dexamethasone—ulcerative colitis	7.63e-05	0.00149	CcSEcCtD
Loperamide—Dizziness—Betamethasone—ulcerative colitis	7.63e-05	0.00149	CcSEcCtD
Loperamide—Nausea—Triamcinolone—ulcerative colitis	7.56e-05	0.00147	CcSEcCtD
Loperamide—Nausea—Methylprednisolone—ulcerative colitis	7.54e-05	0.00147	CcSEcCtD
Loperamide—Fexofenadine—ABCB1—ulcerative colitis	7.48e-05	0.193	CrCbGaD
Loperamide—Hypersensitivity—Prednisone—ulcerative colitis	7.41e-05	0.00144	CcSEcCtD
Loperamide—Vomiting—Betamethasone—ulcerative colitis	7.34e-05	0.00143	CcSEcCtD
Loperamide—Vomiting—Dexamethasone—ulcerative colitis	7.34e-05	0.00143	CcSEcCtD
Loperamide—Rash—Dexamethasone—ulcerative colitis	7.28e-05	0.00142	CcSEcCtD
Loperamide—Rash—Betamethasone—ulcerative colitis	7.28e-05	0.00142	CcSEcCtD
Loperamide—Dermatitis—Betamethasone—ulcerative colitis	7.27e-05	0.00142	CcSEcCtD
Loperamide—Dermatitis—Dexamethasone—ulcerative colitis	7.27e-05	0.00142	CcSEcCtD
Loperamide—Headache—Dexamethasone—ulcerative colitis	7.23e-05	0.00141	CcSEcCtD
Loperamide—Headache—Betamethasone—ulcerative colitis	7.23e-05	0.00141	CcSEcCtD
Loperamide—Asthenia—Prednisone—ulcerative colitis	7.21e-05	0.0014	CcSEcCtD
Loperamide—Pruritus—Prednisone—ulcerative colitis	7.11e-05	0.00138	CcSEcCtD
Loperamide—CYP2B6—lymphoid tissue—ulcerative colitis	6.99e-05	0.0255	CbGeAlD
Loperamide—CALM2—liver—ulcerative colitis	6.92e-05	0.0252	CbGeAlD
Loperamide—CYP2B6—digestive system—ulcerative colitis	6.91e-05	0.0252	CbGeAlD
Loperamide—CALM1—liver—ulcerative colitis	6.89e-05	0.0251	CbGeAlD
Loperamide—Diarrhoea—Prednisone—ulcerative colitis	6.88e-05	0.00134	CcSEcCtD
Loperamide—Nausea—Betamethasone—ulcerative colitis	6.86e-05	0.00133	CcSEcCtD
Loperamide—Nausea—Dexamethasone—ulcerative colitis	6.86e-05	0.00133	CcSEcCtD
Loperamide—Dizziness—Prednisone—ulcerative colitis	6.65e-05	0.00129	CcSEcCtD
Loperamide—Vomiting—Prednisone—ulcerative colitis	6.39e-05	0.00124	CcSEcCtD
Loperamide—Rash—Prednisone—ulcerative colitis	6.34e-05	0.00123	CcSEcCtD
Loperamide—Dermatitis—Prednisone—ulcerative colitis	6.33e-05	0.00123	CcSEcCtD
Loperamide—Headache—Prednisone—ulcerative colitis	6.3e-05	0.00123	CcSEcCtD
Loperamide—Nausea—Prednisone—ulcerative colitis	5.97e-05	0.00116	CcSEcCtD
Loperamide—Clotrimazole—ABCB1—ulcerative colitis	5.78e-05	0.149	CrCbGaD
Loperamide—CYP2C8—liver—ulcerative colitis	5.74e-05	0.0209	CbGeAlD
Loperamide—CYP3A4—digestive system—ulcerative colitis	5.22e-05	0.019	CbGeAlD
Loperamide—Haloperidol—ABCB1—ulcerative colitis	5.2e-05	0.134	CrCbGaD
Loperamide—CYP2B6—liver—ulcerative colitis	5.15e-05	0.0187	CbGeAlD
Loperamide—CYP2D6—digestive system—ulcerative colitis	5.13e-05	0.0187	CbGeAlD
Loperamide—Fentanyl—ABCB1—ulcerative colitis	4.94e-05	0.127	CrCbGaD
Loperamide—ABCB1—epithelium—ulcerative colitis	4.85e-05	0.0177	CbGeAlD
Loperamide—CYP3A4—liver—ulcerative colitis	3.89e-05	0.0142	CbGeAlD
Loperamide—CYP2D6—liver—ulcerative colitis	3.82e-05	0.0139	CbGeAlD
Loperamide—ABCB1—lymphoid tissue—ulcerative colitis	3.74e-05	0.0136	CbGeAlD
Loperamide—ABCB1—digestive system—ulcerative colitis	3.69e-05	0.0134	CbGeAlD
Loperamide—Tamoxifen—ABCB1—ulcerative colitis	3.42e-05	0.0881	CrCbGaD
Loperamide—Methadone—ABCB1—ulcerative colitis	3.39e-05	0.0874	CrCbGaD
Loperamide—ABCB1—liver—ulcerative colitis	2.75e-05	0.01	CbGeAlD
Loperamide—CALM1—Signaling Pathways—MAML2—ulcerative colitis	7.48e-06	8.01e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MAML2—ulcerative colitis	7.48e-06	8.01e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—ADCY5—ulcerative colitis	7.46e-06	7.99e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—IL2—ulcerative colitis	7.41e-06	7.93e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—RELA—ulcerative colitis	7.4e-06	7.93e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—JAK2—ulcerative colitis	7.39e-06	7.92e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—JAK2—ulcerative colitis	7.39e-06	7.92e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CALM3—ulcerative colitis	7.36e-06	7.88e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CALM3—ulcerative colitis	7.36e-06	7.88e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS1—ulcerative colitis	7.35e-06	7.87e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD4—ulcerative colitis	7.25e-06	7.76e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.23e-06	7.75e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CXCL8—ulcerative colitis	7.18e-06	7.69e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PTGER4—ulcerative colitis	7.18e-06	7.69e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—IL2—ulcerative colitis	7.16e-06	7.67e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—IL2—ulcerative colitis	7.16e-06	7.67e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—RELA—ulcerative colitis	7.16e-06	7.67e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—RELA—ulcerative colitis	7.16e-06	7.67e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—ADCY5—ulcerative colitis	7.14e-06	7.65e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—RELA—ulcerative colitis	7.11e-06	7.61e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD4—ulcerative colitis	7.01e-06	7.51e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD4—ulcerative colitis	7.01e-06	7.51e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD4—ulcerative colitis	6.96e-06	7.45e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PTGER4—ulcerative colitis	6.94e-06	7.44e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PTGER4—ulcerative colitis	6.94e-06	7.44e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—ADCY5—ulcerative colitis	6.91e-06	7.4e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—ADCY5—ulcerative colitis	6.91e-06	7.4e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—RELA—ulcerative colitis	6.88e-06	7.36e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—RELA—ulcerative colitis	6.88e-06	7.36e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by NGF—IL6—ulcerative colitis	6.87e-06	7.36e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL2—ulcerative colitis	6.87e-06	7.35e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—ulcerative colitis	6.73e-06	7.21e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—ulcerative colitis	6.73e-06	7.21e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by NGF—IL6—ulcerative colitis	6.65e-06	7.12e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by NGF—IL6—ulcerative colitis	6.65e-06	7.12e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.62e-06	7.09e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—ADCY5—ulcerative colitis	6.59e-06	7.06e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—GHRL—ulcerative colitis	6.57e-06	7.04e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS1—ulcerative colitis	6.41e-06	6.86e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—ADCY5—ulcerative colitis	6.38e-06	6.83e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—ADCY5—ulcerative colitis	6.38e-06	6.83e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—GHRL—ulcerative colitis	6.36e-06	6.81e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—GHRL—ulcerative colitis	6.36e-06	6.81e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.33e-06	6.78e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—JAK2—ulcerative colitis	6.27e-06	6.72e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RIPK2—ulcerative colitis	6.27e-06	6.71e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CRP—ulcerative colitis	6.25e-06	6.69e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—NFKB1—ulcerative colitis	6.24e-06	6.69e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CALM3—ulcerative colitis	6.16e-06	6.59e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CALM3—ulcerative colitis	6.16e-06	6.59e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ABCB1—ulcerative colitis	6.08e-06	6.51e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—RELA—ulcerative colitis	6.08e-06	6.51e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RIPK2—ulcerative colitis	6.06e-06	6.49e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RIPK2—ulcerative colitis	6.06e-06	6.49e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CRP—ulcerative colitis	6.04e-06	6.47e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CRP—ulcerative colitis	6.04e-06	6.47e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—NFKB1—ulcerative colitis	6.04e-06	6.47e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—NFKB1—ulcerative colitis	6.04e-06	6.47e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS1—ulcerative colitis	6.04e-06	6.47e-05	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—NFKB1—ulcerative colitis	5.99e-06	6.42e-05	CbGpPWpGaD
Loperamide—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	5.99e-06	6.42e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—TLR4—ulcerative colitis	5.99e-06	6.41e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DRB1—ulcerative colitis	5.98e-06	6.41e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ABCB1—ulcerative colitis	5.92e-06	6.34e-05	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—NFKB1—ulcerative colitis	5.8e-06	6.21e-05	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—NFKB1—ulcerative colitis	5.8e-06	6.21e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—TLR4—ulcerative colitis	5.79e-06	6.21e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—TLR4—ulcerative colitis	5.79e-06	6.21e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DRB1—ulcerative colitis	5.79e-06	6.2e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DRB1—ulcerative colitis	5.79e-06	6.2e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TGFB1—ulcerative colitis	5.78e-06	6.19e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CALM3—ulcerative colitis	5.77e-06	6.18e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—ICAM1—ulcerative colitis	5.74e-06	6.15e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CXCL8—ulcerative colitis	5.73e-06	6.13e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ABCB1—ulcerative colitis	5.73e-06	6.13e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ABCB1—ulcerative colitis	5.73e-06	6.13e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ADCY5—ulcerative colitis	5.67e-06	6.08e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TGFB1—ulcerative colitis	5.59e-06	5.98e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TGFB1—ulcerative colitis	5.59e-06	5.98e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—ICAM1—ulcerative colitis	5.56e-06	5.95e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—ICAM1—ulcerative colitis	5.56e-06	5.95e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ADCY5—ulcerative colitis	5.52e-06	5.91e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—JAK2—ulcerative colitis	5.5e-06	5.89e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL2—ulcerative colitis	5.47e-06	5.86e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—IL6—ulcerative colitis	5.45e-06	5.83e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADRB2—ulcerative colitis	5.44e-06	5.83e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.44e-06	5.82e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ADCY5—ulcerative colitis	5.34e-06	5.72e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ADCY5—ulcerative colitis	5.34e-06	5.72e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—RELA—ulcerative colitis	5.33e-06	5.71e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADRB2—ulcerative colitis	5.26e-06	5.63e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADRB2—ulcerative colitis	5.26e-06	5.63e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—ulcerative colitis	5.18e-06	5.55e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ABCB1—ulcerative colitis	5.15e-06	5.51e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NFKB1—ulcerative colitis	5.12e-06	5.49e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CDH1—ulcerative colitis	5.08e-06	5.44e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CXCL8—ulcerative colitis	5.02e-06	5.38e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CDH1—ulcerative colitis	4.91e-06	5.26e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CDH1—ulcerative colitis	4.91e-06	5.26e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—JAK2—ulcerative colitis	4.87e-06	5.22e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.8e-06	5.14e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL2—ulcerative colitis	4.8e-06	5.14e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—IL6—ulcerative colitis	4.78e-06	5.11e-05	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—TP53—ulcerative colitis	4.76e-06	5.09e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—JAK2—ulcerative colitis	4.71e-06	5.05e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—JAK2—ulcerative colitis	4.71e-06	5.05e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—JAK2—ulcerative colitis	4.65e-06	4.98e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—ADCY5—ulcerative colitis	4.62e-06	4.94e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—STAT3—ulcerative colitis	4.61e-06	4.93e-05	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—TP53—ulcerative colitis	4.6e-06	4.93e-05	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—TP53—ulcerative colitis	4.6e-06	4.93e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—ulcerative colitis	4.54e-06	4.86e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—RELA—ulcerative colitis	4.5e-06	4.82e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NFKB1—ulcerative colitis	4.49e-06	4.81e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—ADCY5—ulcerative colitis	4.47e-06	4.78e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—ADCY5—ulcerative colitis	4.47e-06	4.78e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—JAK2—ulcerative colitis	4.45e-06	4.77e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CXCL8—ulcerative colitis	4.45e-06	4.76e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IFNG—ulcerative colitis	4.37e-06	4.68e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—RELA—ulcerative colitis	4.31e-06	4.62e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—JAK2—ulcerative colitis	4.31e-06	4.61e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—JAK2—ulcerative colitis	4.31e-06	4.61e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CXCL8—ulcerative colitis	4.3e-06	4.61e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CXCL8—ulcerative colitis	4.3e-06	4.61e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TGFB1—ulcerative colitis	4.27e-06	4.57e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL2—ulcerative colitis	4.25e-06	4.55e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CXCL8—ulcerative colitis	4.24e-06	4.54e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PPARG—ulcerative colitis	4.23e-06	4.53e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IFNG—ulcerative colitis	4.23e-06	4.53e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IFNG—ulcerative colitis	4.23e-06	4.53e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.23e-06	4.53e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—ulcerative colitis	4.22e-06	4.52e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ADCY5—ulcerative colitis	4.18e-06	4.48e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—RELA—ulcerative colitis	4.17e-06	4.47e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—RELA—ulcerative colitis	4.17e-06	4.47e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PPARG—ulcerative colitis	4.12e-06	4.41e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL2—ulcerative colitis	4.11e-06	4.4e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL2—ulcerative colitis	4.11e-06	4.4e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—JAK2—ulcerative colitis	4.11e-06	4.4e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—ulcerative colitis	4.08e-06	4.37e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—ulcerative colitis	4.08e-06	4.37e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL2—ulcerative colitis	4.06e-06	4.34e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—STAT3—ulcerative colitis	4.04e-06	4.32e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—IL6—ulcerative colitis	4.04e-06	4.32e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PPARG—ulcerative colitis	3.98e-06	4.27e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PPARG—ulcerative colitis	3.98e-06	4.27e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—JAK2—ulcerative colitis	3.98e-06	4.26e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—JAK2—ulcerative colitis	3.98e-06	4.26e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.95e-06	4.23e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.94e-06	4.22e-05	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—IL6—ulcerative colitis	3.92e-06	4.2e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL1B—ulcerative colitis	3.9e-06	4.17e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—ulcerative colitis	3.9e-06	4.17e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL2—ulcerative colitis	3.88e-06	4.16e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—PTGS2—ulcerative colitis	3.87e-06	4.14e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—ulcerative colitis	3.84e-06	4.11e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ALB—ulcerative colitis	3.8e-06	4.07e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NFKB1—ulcerative colitis	3.8e-06	4.07e-05	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—IL6—ulcerative colitis	3.79e-06	4.06e-05	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—IL6—ulcerative colitis	3.79e-06	4.06e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL1B—ulcerative colitis	3.77e-06	4.04e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL1B—ulcerative colitis	3.77e-06	4.04e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—ulcerative colitis	3.77e-06	4.04e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—ulcerative colitis	3.77e-06	4.04e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL2—ulcerative colitis	3.76e-06	4.02e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL2—ulcerative colitis	3.76e-06	4.02e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TGFB1—ulcerative colitis	3.74e-06	4.01e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—PTGS2—ulcerative colitis	3.74e-06	4.01e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—PTGS2—ulcerative colitis	3.74e-06	4.01e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ALB—ulcerative colitis	3.7e-06	3.97e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—NFKB1—ulcerative colitis	3.64e-06	3.89e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.58e-06	3.84e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ALB—ulcerative colitis	3.58e-06	3.84e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ALB—ulcerative colitis	3.58e-06	3.84e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.55e-06	3.81e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—NFKB1—ulcerative colitis	3.52e-06	3.77e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—NFKB1—ulcerative colitis	3.52e-06	3.77e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TP53—ulcerative colitis	3.51e-06	3.76e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—STAT3—ulcerative colitis	3.41e-06	3.65e-05	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—PTGS2—ulcerative colitis	3.33e-06	3.56e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—STAT3—ulcerative colitis	3.27e-06	3.5e-05	CbGpPWpGaD
Loperamide—CALM3—Metabolism—PTGS2—ulcerative colitis	3.24e-06	3.47e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ALB—ulcerative colitis	3.22e-06	3.45e-05	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—IL6—ulcerative colitis	3.22e-06	3.44e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TGFB1—ulcerative colitis	3.16e-06	3.39e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—STAT3—ulcerative colitis	3.16e-06	3.39e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—STAT3—ulcerative colitis	3.16e-06	3.39e-05	CbGpPWpGaD
Loperamide—CALM1—Metabolism—PTGS2—ulcerative colitis	3.13e-06	3.36e-05	CbGpPWpGaD
Loperamide—CALM2—Metabolism—PTGS2—ulcerative colitis	3.13e-06	3.36e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PPARG—ulcerative colitis	3.12e-06	3.34e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TP53—ulcerative colitis	3.08e-06	3.3e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—STAT3—ulcerative colitis	3.02e-06	3.23e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.94e-06	3.15e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—STAT3—ulcerative colitis	2.92e-06	3.13e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—STAT3—ulcerative colitis	2.92e-06	3.13e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—JAK2—ulcerative colitis	2.88e-06	3.08e-05	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—IL6—ulcerative colitis	2.82e-06	3.02e-05	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.82e-06	3.02e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ALB—ulcerative colitis	2.81e-06	3.01e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—TGFB1—ulcerative colitis	2.8e-06	2.99e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—RELA—ulcerative colitis	2.79e-06	2.99e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—JAK2—ulcerative colitis	2.78e-06	2.98e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—JAK2—ulcerative colitis	2.78e-06	2.98e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.76e-06	2.96e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—TGFB1—ulcerative colitis	2.71e-06	2.9e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—TGFB1—ulcerative colitis	2.71e-06	2.9e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—RELA—ulcerative colitis	2.7e-06	2.89e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—RELA—ulcerative colitis	2.7e-06	2.89e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ALB—ulcerative colitis	2.64e-06	2.83e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CXCL8—ulcerative colitis	2.63e-06	2.81e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TP53—ulcerative colitis	2.6e-06	2.79e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.58e-06	2.76e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CXCL8—ulcerative colitis	2.54e-06	2.72e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CXCL8—ulcerative colitis	2.54e-06	2.72e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL2—ulcerative colitis	2.51e-06	2.69e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—IL6—ulcerative colitis	2.5e-06	2.68e-05	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—PTGS2—ulcerative colitis	2.46e-06	2.63e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL2—ulcerative colitis	2.43e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL2—ulcerative colitis	2.43e-06	2.6e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—IL6—ulcerative colitis	2.42e-06	2.59e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—IL6—ulcerative colitis	2.42e-06	2.59e-05	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—IL6—ulcerative colitis	2.38e-06	2.55e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—ulcerative colitis	2.38e-06	2.54e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NFKB1—ulcerative colitis	2.35e-06	2.52e-05	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.31e-06	2.48e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—ulcerative colitis	2.3e-06	2.46e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—ulcerative colitis	2.3e-06	2.46e-05	CbGpPWpGaD
Loperamide—CALM3—Immune System—IL6—ulcerative colitis	2.28e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NFKB1—ulcerative colitis	2.27e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NFKB1—ulcerative colitis	2.27e-06	2.44e-05	CbGpPWpGaD
Loperamide—CALM1—Immune System—IL6—ulcerative colitis	2.21e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM2—Immune System—IL6—ulcerative colitis	2.21e-06	2.36e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—STAT3—ulcerative colitis	2.11e-06	2.26e-05	CbGpPWpGaD
Loperamide—CALM3—Disease—IL6—ulcerative colitis	2.11e-06	2.26e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—STAT3—ulcerative colitis	2.04e-06	2.19e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—STAT3—ulcerative colitis	2.04e-06	2.19e-05	CbGpPWpGaD
Loperamide—CALM2—Disease—IL6—ulcerative colitis	2.04e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM1—Disease—IL6—ulcerative colitis	2.04e-06	2.18e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TGFB1—ulcerative colitis	1.96e-06	2.1e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.92e-06	2.06e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TGFB1—ulcerative colitis	1.89e-06	2.03e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TGFB1—ulcerative colitis	1.89e-06	2.03e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ALB—ulcerative colitis	1.73e-06	1.85e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TP53—ulcerative colitis	1.61e-06	1.73e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TP53—ulcerative colitis	1.56e-06	1.67e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TP53—ulcerative colitis	1.56e-06	1.67e-05	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.51e-06	1.62e-05	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—IL6—ulcerative colitis	1.48e-06	1.58e-05	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—IL6—ulcerative colitis	1.43e-06	1.53e-05	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—IL6—ulcerative colitis	1.43e-06	1.53e-05	CbGpPWpGaD
